Glaukos (GKOS) Profit After Tax Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.73% |
| Dec 31, 2025 | -65.86% |
| Sep 30, 2025 | -0.61% |
| Jun 30, 2025 | 13.20% |
| Mar 31, 2025 | 19.61% |
| Dec 31, 2024 | -23.88% |
| Sep 30, 2024 | -9.65% |
| Jun 30, 2024 | -51.62% |
| Mar 31, 2024 | -98.00% |
| Dec 31, 2023 | -86.68% |
| Sep 30, 2023 | -35.68% |
| Jun 30, 2023 | -43.47% |
| Mar 31, 2023 | -66.44% |
| Dec 31, 2022 | -101.57% |
| Sep 30, 2022 | -86.91% |
| Jun 30, 2022 | -69.02% |
| Mar 31, 2022 | 43.68% |
| Dec 31, 2021 | -177.72% |
| Sep 30, 2021 | 39.98% |
| Jun 30, 2021 | -56.86% |
| Mar 31, 2021 | -82.71% |
| Dec 31, 2020 | -35.98% |
| Sep 30, 2020 | -50.24% |
| Jun 30, 2020 | -4.18% |
| Mar 31, 2020 | -123.65% |
| Dec 31, 2019 | 58.31% |
| Sep 30, 2019 | -55.43% |
| Jun 30, 2019 | -20.40% |
| Mar 31, 2019 | 19.45% |